Kinetics of fetal cellular and cell-free DNA in the maternal circulation during and after pregnancy: Implications for noninvasive prenatal diagnosis

Transfusion

Volumn 41, Issue 12, 2001, Pages 1524-1530

  Ariga, Hiromichi ^a   Ohto, Hitoshi ^a   Busch, Michael P ^a   Imamura, Shinya ^a   Watson, Robert ^a   Reed, William ^a   Lee, Tzong Hae ^a  

^a Blood Centers of the Pacific   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; PHOSPHORUS 32;

ADULT; ARTICLE; CELL FREE SYSTEM; CLINICAL ARTICLE; DNA DETERMINATION; FEMALE; FETUS; FETUS CELL; GENETIC ANALYSIS; HUMAN; HYBRIDIZATION; ISOTOPE LABELING; KINETICS; MALE; POLYMERASE CHAIN REACTION; PREGNANCY; PRENATAL DIAGNOSIS; PROSPECTIVE STUDY; Y CHROMOSOME;

ADULT; DNA; FEMALE; FETUS; GESTATIONAL AGE; HUMANS; KINETICS; MALE; MATERNAL-FETAL EXCHANGE; POLYMERASE CHAIN REACTION; PREGNANCY; PRENATAL DIAGNOSIS; PROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY; Y CHROMOSOME;

EID: 0035686617     PISSN: 00411132     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1537-2995.2001.41121524.x     Document Type: Article

References (55)

1. Human fetomaternal passage of erythrocytes
2. Maternofetal passage of leukocytes and platelets in man
3. The transmission of chromium-51 tagged maternal erythrocytes from mother to fetus
4. Fetomaternal transplacental hemorrhage during pregnancy and after delivery
5. Two-way cell traffic between mother and fetus: Biologic and clinical implications
6. Search for maternal cells in human umbilical cord blood by polymerase chain reaction by amplification of two minisatellite sequences
7. The correlation of prolonged survival of maternal skin grafts with the presence of naturally transferred maternal T cells
8. Induction of B cell unresponsiveness to noninherited maternal HLA antigens during fetal life
9. Male fetal progenitor cells persist in maternal blood for as long as 27 years postpartum
10. Long-term fetal microchimerism in peripheral blood mononuclear cell subsets in healthy women and women with scleroderma
11. Identification of fetal DNA and cells in skin lesions from women with systemic sclerosis
12. Microchimerism and HLA-compatible relationships of pregnancy in scleroderma
13. Maternal-fetal disparity in HLA class II alloantigens and the pregnancy-induced amelioration of rheumatoid arthritis
14. Trophoblast in the circulating blood during pregnancy
15. Isolation of fetal trophoblast cells from peripheral blood of pregnant women
16. Isolation of fetal DNA from nucleated erythrocytes in maternal blood
17. Fetal cells in the blood of pregnant women: Detection and enrichment by fluorescence-activated cell sorting
18. Frequency of fetal cells in sorted subpopulations of nucleated erythroid and CD34+ hematopoietic progenitor cells from maternal peripheral blood
19. Practical and theoretical implications of fetal-maternal lymphocyte transfer
20. Fetal granulocytes in maternal venous blood detected by in situ hybridization
21. PCR quantitation of fetal cells in maternal blood in normal and aneuploid pregnancies
22. Fetal cells in maternal circulation throughout gestation
23. Fetal nucleated cells in maternal peripheral blood: Frequency and relationship to gestational age
24. Frequencies of fetal nucleated red blood cells in maternal blood during different stages of gestation
25. Development of non-invasive fetal DNA diagnosis from maternal blood
26. The time of appearance and disappearance of fetal DNA from the maternal circulation
27. Frequency of nucleated red blood cells in maternal blood during the different gestational ages
28. Rare-event analysis methods for detection of fetal red blood cells in maternal blood
29. Enrichment of fetal nucleated red blood cells from the maternal circulation for prenatal diagnosis: Experiences with triple density gradient and MACS based on more than 600 cases
30. Charge flow separation: Quantification of nucleated red blood cells in maternal blood during pregnancy
31. Enrichment of fetal trophoblasts and nucleated erythrocytes from maternal blood by an immunomagnetic colloid system
32. Quantitative analysis of fetal DNA in maternal plasma and serum: Implications for noninvasive prenatal diagnosis
33. Presence of fetal DNA in maternal plasma and serum
34. Increased fetal DNA concentrations in the plasma of pregnant women carrying fetuses with trisomy 21
35. Quantitative abnormalities of fetal DNA in maternal serum in preeclampsia
36. Prenatal detection of fetal Down's syndrome from maternal plasma
37. Cell-free fetal deoxyribonucleic acid in maternal circulation as a marker of fetal-maternal hemorrhage in patients undergoing external cephalic version near term
38. Fetal DNA in maternal plasma: Biology and diagnostic applications
39. Quantitation of white cell subpopulations by polymerase chain reaction using frozen whole-blood samples. Viral Activation Transfusion Study
40. Kinetic PCR analysis: Real-time monitoring of DNA amplification reactions
41. Simultaneous amplification and detection of specific DNA sequences
42. A gene from the human sex-determining region encodes a protein with homology to a conserved DNA-binding motif
43. A class I antigen, HLA-G, expressed in human trophoblasts
44. A soluble form of the HLA-G antigen is encoded by a messenger ribonucleic acid containing intron 4
45. Detection of soluble HLA-G levels in maternal serum can be predictive for a successful pregnancy
46. HLA-G isoforms produced by placental cytotrophoblasts and found in amniotic fluid are due to unusual glycosylation
47. Detection of soluble HLA-G molecules in plasma and amniotic fluid
48. Direct evidence to support the role of HLA-G in protecting the fetus from maternal uterine natural killer cytolysis
49. Altered expression of human leukocyte antigen G (HLA-G) on extravillous trophoblasts in preeclampsia: Immunohistological demonstration with anti-HLA-G specific antibody "87G" and anticytokeratin antibody "CAM5.2"
50. Disturbed fetomaternal cell traffic in preeclampsia
51. Prenatal diagnosis by use of fetal cells isolated from maternal blood
52. Fetal cells in maternal blood of pregnancies with severe fetal growth restriction
53. Nucleated red blood cells as a marker of acidemia in term neonates
54. Detection of fetal HPCs in maternal circulation after delivery
55. The maternal immune system's interaction with circulating fetal cells